Harmony Biosciences Holdings, Inc. (HRMY)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 1.71B |
| Enterprise value | 1.53B |
| Trailing P/E | 12.96 |
| Forward P/E | 20.75 |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 2.90 |
| Price/book (mrq) | 3.31 |
| Enterprise value/revenue | 2.47 |
| Enterprise value/EBITDA | 6.51 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.72 |
| 52-week change 3 | -13.58% |
| S&P500 52-week change 3 | 24.96% |
| 52-week high 3 | 39.26 |
| 52-week low 3 | 18.61 |
| 50-day moving average 3 | 29.82 |
| 200-day moving average 3 | 30.52 |
Share statistics
| Avg vol (3-month) 3 | 387.65k |
| Avg vol (10-day) 3 | 432.06k |
| Shares outstanding 5 | 56.79M |
| Implied shares outstanding 6 | 56.79M |
| Float 8 | 34.64M |
| % held by insiders 1 | 19.77% |
| % held by institutions 1 | 91.88% |
| Shares short (15 May 2024) 4 | 7.09M |
| Short ratio (15 May 2024) 4 | 15.77 |
| Short % of float (15 May 2024) 4 | 55.90% |
| Short % of shares outstanding (15 May 2024) 4 | 12.49% |
| Shares short (prior month 15 Apr 2024) 4 | 6.46M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 22.30% |
| Operating margin (ttm) | 33.65% |
Management effectiveness
| Return on assets (ttm) | 16.30% |
| Return on equity (ttm) | 28.73% |
Income statement
| Revenue (ttm) | 617.51M |
| Revenue per share (ttm) | 10.52 |
| Quarterly revenue growth (yoy) | 29.80% |
| Gross profit (ttm) | N/A |
| EBITDA | 228.06M |
| Net income avi to common (ttm) | 137.7M |
| Diluted EPS (ttm) | 2.32 |
| Quarterly earnings growth (yoy) | 30.00% |
Balance sheet
| Total cash (mrq) | 372.35M |
| Total cash per share (mrq) | 6.56 |
| Total debt (mrq) | 193.06M |
| Total debt/equity (mrq) | 37.46% |
| Current ratio (mrq) | 3.11 |
| Book value per share (mrq) | 9.07 |
Cash flow statement
| Operating cash flow (ttm) | 207.97M |
| Levered free cash flow (ttm) | 202.42M |
© 2024 Yahoo. All rights reserved.